These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20227612)

  • 1. Avastin as monotherapy for retinopathy of prematurity.
    Mintz-Hittner HA
    J AAPOS; 2010 Feb; 14(1):2-3. PubMed ID: 20227612
    [No Abstract]   [Full Text] [Related]  

  • 2. Comment on "Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity".
    Er H
    Retina; 2009 Oct; 29(9):1380; author reply 1379-80. PubMed ID: 19934833
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.
    O'Keefe M
    Ir Med J; 2011; 104(7):197. PubMed ID: 21957683
    [No Abstract]   [Full Text] [Related]  

  • 4. Bevacizumab for retinopathy of prematurity.
    Gole GA; Camuglia JE; Ells AL
    N Engl J Med; 2011 Jun; 364(24):2360-1; author reply 2362. PubMed ID: 21675896
    [No Abstract]   [Full Text] [Related]  

  • 5. Bevacizumab for retinopathy of prematurity.
    Reynolds JD
    N Engl J Med; 2011 Feb; 364(7):677-8. PubMed ID: 21323546
    [No Abstract]   [Full Text] [Related]  

  • 6. Bevacizumab for retinopathy of prematurity.
    Good WV; Palmer EA
    N Engl J Med; 2011 Jun; 364(24):2359; author reply 2361-2. PubMed ID: 21675899
    [No Abstract]   [Full Text] [Related]  

  • 7. Bevacizumab for retinopathy of prematurity.
    Gilbert CE; Zin A; Darlow B
    N Engl J Med; 2011 Jun; 364(24):2359-60; author reply 2361-2. PubMed ID: 21675898
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of type 1 retinopathy of prematurity with intravitreal bevacizumab (Avastin).
    Dorta P; Kychenthal A
    Retina; 2010 Apr; 30(4 Suppl):S24-31. PubMed ID: 20224475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bevacizumab for retinopathy of prematurity.
    Lim LS; Mitchell P; Wong TY
    N Engl J Med; 2011 Jun; 364(24):2360; author reply 2361-2. PubMed ID: 21675897
    [No Abstract]   [Full Text] [Related]  

  • 10. Bevacizumab (avastin) for the treatment of retinopathy of prematurity.
    Beaulieu MJ
    Neonatal Netw; 2012; 31(4):242-7. PubMed ID: 22763251
    [No Abstract]   [Full Text] [Related]  

  • 11. Paradoxical vascular-fibrotic reaction after intravitreal bevacizumab for retinopathy of prematurity.
    Zepeda-Romero LC; Liera-Garcia JA; Gutiérrez-Padilla JA; Valtierra-Santiago CI; Avila-Gómez CD
    Eye (Lond); 2010 May; 24(5):931-3. PubMed ID: 19557020
    [No Abstract]   [Full Text] [Related]  

  • 12. Intravitreous bevacizumab as anti-vascular endothelial growth factor therapy for retinopathy of prematurity: a morphologic study.
    Kong L; Mintz-Hittner HA; Penland RL; Kretzer FL; Chévez-Barrios P
    Arch Ophthalmol; 2008 Aug; 126(8):1161-3. PubMed ID: 18695118
    [No Abstract]   [Full Text] [Related]  

  • 13. Bevacizumab (Avastin) for retinopathy of prematurity: wrong dose, wrong drug, or both?
    Avery RL
    J AAPOS; 2012 Feb; 16(1):2-4. PubMed ID: 22237669
    [No Abstract]   [Full Text] [Related]  

  • 14. Is Avastin the right choice of treatment for retinopathy of prematurity?
    Käll A
    Acta Paediatr; 2012 Aug; 101(8):796-8. PubMed ID: 22788788
    [No Abstract]   [Full Text] [Related]  

  • 15. Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity.
    Lalwani GA; Berrocal AM; Murray TG; Buch M; Cardone S; Hess D; Johnson RA; Puliafito CA
    Retina; 2008 Mar; 28(3 Suppl):S13-8. PubMed ID: 18317338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label use of bevacizumab in retinopathy of prematurity.
    Rishi E; Rishi P; Ratra D; Bhende M
    Retina; 2009 Feb; 29(2):284; author reply 284-5. PubMed ID: 18854784
    [No Abstract]   [Full Text] [Related]  

  • 17. Concentration of vascular endothelial growth factor in aqueous humor of eyes with advanced retinopathy of prematurity before and after intravitreal injection of bevacizumab.
    Nonobe NI; Kachi S; Kondo M; Takai Y; Takemoto K; Nakayama A; Hayakawa M; Terasaki H
    Retina; 2009 May; 29(5):579-85. PubMed ID: 19430279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bilateral effect of unilateral bevacizumab injection in retinopathy of prematurity.
    Karaca C; Oner AO; Mirza E; Polat OA; Sahiner M
    JAMA Ophthalmol; 2013 Aug; 131(8):1099-101. PubMed ID: 23744183
    [No Abstract]   [Full Text] [Related]  

  • 19. Early refractive outcome after intravitreous bevacizumab for retinopathy of prematurity.
    Harder BC; von Baltz S; Schlichtenbrede FC; Jonas JB
    Arch Ophthalmol; 2012 Jun; 130(6):800-1. PubMed ID: 22801850
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravitreal bevacizumab for the treatment of retinopathy of prematurity: a case report.
    Flavahan PW; Lavy TE; Wykes W
    Scott Med J; 2013 Aug; 58(3):130-2. PubMed ID: 23960050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.